Compare Inovio Pharmaceuticals Inc (INO) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs TotalEnergies SE — how do they compare? Inovio Pharmaceuticals Inc trades at $1.15 (market cap $112.19M), while TotalEnergies SE trades at $86.11 (market cap $191.82B). The key difference: TotalEnergies SE is far larger — about 1709.8× Inovio Pharmaceuticals Inc's market cap, and TotalEnergies SE pays a 4.93% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and TotalEnergies SE for 90 Days on average.
| INO | TTE | |
|---|---|---|
Market Cap | $112.19M | $191.82B |
Volume | 3,201,278 | 3,311,339 |
Sector | Health | Energy |
52-Week High | $2.65 | $93.60 |
52-Week Low | $0.66 | $57.39 |
Typical Hold Time | 43 Days | 90 Days |
Enterprise Value | $83.51M | $222.81B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO Pharmaceuticals trades at $1.09, down 5.63% today, with a bearish technical outlook despite positive analyst sentiment. The company faces significant fundamental challenges with minimal revenue of $65,340 in 2025 and substantial losses of $84.95 million. Key catalyst is the October 30, 2026 FDA decision on INO-3107 for recurrent respiratory papillomatosis, which could transform the company's prospects if approved.
Investment outlook hinges on FDA approval of INO-3107, with analysts maintaining a $2.75 consensus target representing 152% upside. However, persistent cash burn and negative profitability metrics pose substantial risks. The stock offers high-risk, high-reward potential for investors comfortable with binary regulatory outcomes in biotech.
TotalEnergies (TTE) trades at $86.02, up 2.13% today, with a bearish technical signal but strong fundamentals including a P/E of 10.77 and ROE of 14.56%. Recent earnings beat expectations in Q1 and Q2 2026, and the company announced a $10 billion investment in Argentina and increased share buybacks to $2.5 billion, signaling growth commitment. Cash flow trends show a recovery to positive net cash flow in 2025 after declines in prior years.
The outlook is positive with a consensus price target of $95.33, representing 10.8% upside, supported by 55.88% analyst buy ratings. Risks include declining revenue from $263.3B in 2022 to $182.3B in 2025 and rising debt-to-asset ratio to 20.17% in 2025. Strategic investments in LNG and power diversification offer long-term growth, but oil price volatility and execution risks remain key concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
